AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

14,006.00p
   
  • Change Today:
      56.00p
  • 52 Week High: 15,316.00
  • 52 Week Low: 10,120.00
  • Currency: UK Pounds
  • Shares Issued: 1,551.00m
  • Volume: 925,986
  • Market Cap: £217,232m
  • RiskGrade: 123
  • Beta: 0.00

Key dates

Dividend  
Latest XD Date (2nd Interim) 19-Feb-2026
Latest Pay Date (2nd Interim) 23-Mar-2026
   
Meetings  
AGM 09-Apr-2026
EGM n/a
GMs n/a
   
Announcements  
Trading announcement n/a
IMSs n/a
Drilling Report n/a
   
Results  
Final results 10-Feb-2026
Interim results 29-Jul-2025
Q1 Results 29-Apr-2026
Q2 Results 29-Jul-2025
Q3 Results 06-Nov-2025
Q4 Results 10-Feb-2026
Annual Report 24-Feb-2026
   
Year End 31-Dec-2026

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,006.00p
Change Today 56.00p
% Change 0.40 %
52 Week High 15,316.00
52 Week Low 10,120.00
Volume 925,986
Shares Issued 1,551.00m
Market Cap £217,232m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 19-Feb-26 07-Aug-25
Paid 23-Mar-26 08-Sep-25
Amount 217.00¢ 103.00¢

Trades for 21-May-2026

Time Volume / Share Price
16:24 1 @ 14,036.00p
16:23 0 @ 14,032.00p
16:35 131 @ 14,006.00p
16:35 1,334 @ 14,006.00p
16:35 119 @ 14,006.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page